Nuvama sees 37% upside in this healthcare stock. Should you buy?
Healthcare stock Park Medi World (PARKHOSP) is poised to benefit from India’s structural shortage of hospital beds, improving reimbursement dynamics and faster healthcare growth in Tier II markets, Nuvama said while initiating coverage. With improving balance sheet quality and visible growth drivers, Nuvama has initiated coverage with a ‘Buy’ rating and a target price of…